Articles Archive - Page 326 of 330

Therapies Aimed at Immune Cell Progenitors May Be Key to Reducing Post Myocardial Infarction Risk

Lara C. Pullen, PhD | November 9, 2012

Researchers have identified hematopoietic stem and progenitor cells that are liberated from bone marrow niches by a myocardial infarction.

Gadolinium Compounds Provide Insights into Pathogenesis of Fibrosing Diseases

Lara C. Pullen, PhD | November 9, 2012

Toll-like receptors appear to play an important role in the pathogenesis of fibrotic disorders including nephrogenic systemic fibrosis and systemic sclerosis.

Rheumatologists Seek Public Vote for Research Grant Award

Michael O’Neal | October 17, 2012

Brigham and Women’s docs compete for BRIght Futures Prize for personalized medicine research

South Korea Okays First Officially Approved Monoclonal Antibody for RA

Kurt Ullman | October 17, 2012

11 Products Looking for U.S. Marketing Nod

Neutralizing IL-23 and Its Targets May Improve Ankylosing Spondylitis

Lara C. Pullen, PhD | August 30, 2012

Researchers have identified a unique population of entheseal resident cells that can be activated by interleukin 23 (IL-23). This finding may be key to understanding how dysregulation of IL-23 results in precise inflammation of the entheses.

Newly Discovered Molecule Modulates Cartilage Repair

Lara C. Pullen, PhD | August 29, 2012

Chondrocytes play an important role in cartilage repair as well as symptom relief. Research published in Science provides insights into the role of stem cell–based therapies in the promotion of chondrogenesis and cartilage repair.

ACA Upheld: What Does This Mean for Rheumatology?

Richard Quinn | August 17, 2012

What does the Supreme Court decision to uphold the Affordable Care Act mean for rheumatologists?

Gene Mutation Could Cause Gut Microbe Changes that Lead to RA

David Holzman | July 31, 2012

A new study suggests that a small abnormality in an immunity gene can alter the gut flora in a way that induces development of rheumatoid arthritis.

Letter: Skepticism on Steroids in RA

Staff | July 24, 2012

There is not a consensus between all European rheumatologists regarding the use of steroids in RA; quite a few share your skepticism.

New Lupus Insight Prize Aims to Advance Lupus Research

Dawn Antoline | July 2, 2012

The Lupus Insight Prize will provide $200,000 to one researcher to help fund a project dedicated to furthering understanding of the genetic, environmental, molecular, immunologic, or cellular aspects of lupus or its treatment.